Skip to content

Analgesia, sedation and early mobilization therapies during mechanically ventilation in ICU: a real-world, multicentre observational study

Analgesia, sedation and early mobilization therapies during mechanically ventilation in ICU: a real-world, multicentre observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095744
Enrollment
Unknown
Registered
2025-01-13
Start date
2025-01-15
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mechanically ventilated patients

Interventions

Deep sedation (RASS score: -5 to -3):None
light sedation (RASS score: -2 to +1):None

Sponsors

Jinling Hospital Affiliated to Nanjing University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >=18 years old; 2.Patients who have received mechanical ventilation within the previous 24 hours and are expected to stay in ICU and remain ventilated for 48 hours; 3.Patients receiving sedation and analgesia.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women; 2.Contraindications to sedative, analgesic drugs or their excipients; 3.Suspected or confirmed primary brain injury (traumatic brain injury, cerebral infarction, intracranial hemorrhage, hypoxic-ischemic encephalopathy, hydrocephalus, respiratory cardiac arrest, or neurological infection); 4.Patients with confirmed or suspected spinal cord injury (any part of the spinal cord injury affecting the movement of limbs), myasthenia, or other neuromuscular disease that will cause permanent or long-term myasthenia; 5.End-stage liver disease (Child-Pugh Grade C); 6.Patients with contraindications to activity (patients with deep vein thrombosis and fractures requiring immobilization); 7.Tracheotomy in 48 hours; 8.Receiving palliative care or expected to die within 48 hours; 9.History of dementia or mental illness and are taking psychotropic drugs; 10.History of drug abuse; 11.Patients who have been in the study.

Design outcomes

Primary

MeasureTime frame
Ventilator-free days within 28 days;

Secondary

MeasureTime frame
New onset organ failure;New receipt of organ support therapy;Mortality;delirium;length of ICU stay;Analgesia compliance rate;Sedation compliance rate;VAP;[6]the patient's ability to move their limbs at the time of ICU exit;;Unplanned extubation;nourishment state;

Countries

China

Contacts

Public ContactKe Lu

Jinling Hospital, Medical School of Nanjing University

ctgkelu@nju.edu.cn+86 158 5076 8321

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026